{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:55:39Z","timestamp":1790970939553,"version":"4.1.0"},"reference-count":221,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health-Ricerca Corrente to IRCCS MultiMedica"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03247-4","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:45:13Z","timestamp":1781322313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gestational diabetes as an inter-generational cardiometabolic risk factor: spotlight on emerging exerkines"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-1564","authenticated-orcid":false,"given":"Pamela","family":"Senesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-0552","authenticated-orcid":false,"given":"Livio","family":"Luzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-8831","authenticated-orcid":false,"given":"Andrea","family":"Sonaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2847-6742","authenticated-orcid":false,"given":"Flavia","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2164-6823","authenticated-orcid":false,"given":"Elisa","family":"Cipponeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8518-5547","authenticated-orcid":false,"given":"Anna","family":"Ferrulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"10","key":"3247_CR1","doi-asserted-by":"publisher","first-page":"e47500","DOI":"10.7759\/cureus.47500","volume":"15","author":"VS Nakshine","year":"2023","unstructured":"Nakshine VS, Jogdand SD. A comprehensive review of gestational diabetes mellitus: impacts on maternal health, fetal development, childhood outcomes, and long-term treatment strategies. Cureus. 2023;15(10):e47500. https:\/\/doi.org\/10.7759\/cureus.47500.","journal-title":"Cureus"},{"issue":"1","key":"3247_CR2","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1210\/clinem\/dgae709","volume":"110","author":"HD McIntyre","year":"2024","unstructured":"McIntyre HD, Kampmann U, Dalsgaard Clausen T, Laurie J, Ma RCW. Gestational diabetes: an update 60 years after O\u2019Sullivan and Mahan. J Clin Endocrinol Metab. 2024;110(1):e19\u201331. https:\/\/doi.org\/10.1210\/clinem\/dgae709.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3247_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","volume":"62","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905\u201314. https:\/\/doi.org\/10.1007\/s00125-019-4840-2.","journal-title":"Diabetologia"},{"key":"3247_CR4","doi-asserted-by":"publisher","first-page":"l6398","DOI":"10.1136\/bmj.l6398","volume":"367","author":"Y Yu","year":"2019","unstructured":"Yu Y, Arah OA, Liew Z, Cnattingius S, Olsen J, S\u00f8rensen HT, et al. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. BMJ. 2019;367:l6398. https:\/\/doi.org\/10.1136\/bmj.l6398.","journal-title":"BMJ"},{"issue":"8","key":"3247_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/dc18-2581","volume":"42","author":"KA Page","year":"2019","unstructured":"Page KA, Luo S, Wang X, Chow T, Alves J, Buchanan TA, et al. Children exposed to maternal obesity or gestational diabetes mellitus during early fetal development have hypothalamic alterations that predict future weight gain. Diabetes Care. 2019;42(8):1473\u201380. https:\/\/doi.org\/10.2337\/dc18-2581.","journal-title":"Diabetes Care"},{"key":"3247_CR6","doi-asserted-by":"publisher","first-page":"596060","DOI":"10.1155\/2011\/596060","volume":"2011","author":"MC Battista","year":"2011","unstructured":"Battista MC, Hivert MF, Duval K, Baillargeon JP. Intergenerational cycle of obesity and diabetes: How can we reduce the burdens of these conditions on the health of future generations? Exp Diabetes Res. 2011;2011:596060. https:\/\/doi.org\/10.1155\/2011\/596060.","journal-title":"Exp Diabetes Res"},{"issue":"14","key":"3247_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145003","volume":"21","author":"EU Alejandro","year":"2020","unstructured":"Alejandro EU, Mamerto TP, Chung G, Villavieja A, Gaus NL, Morgan E, et al. Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. Int J Mol Sci. 2020;21(14):5003. https:\/\/doi.org\/10.3390\/ijms21145003.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3247_CR8","doi-asserted-by":"publisher","first-page":"e79334","DOI":"10.7759\/cureus.79334","volume":"17","author":"RA Albairmani","year":"2025","unstructured":"Albairmani RA, Basheer BM, Macky MM, Al Syouti T, AlZubaidy H, Elfaki E, et al. Management of diabetes in pregnancy: a review of clinical guidelines and practices. Cureus. 2025;17(2):e79334. https:\/\/doi.org\/10.7759\/cureus.79334.","journal-title":"Cureus"},{"issue":"3","key":"3247_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1471-0528.17304","volume":"130","author":"V Mart\u00ednez-Vizca\u00edno","year":"2023","unstructured":"Mart\u00ednez-Vizca\u00edno V, Sanabria-Mart\u00ednez G, Fern\u00e1ndez-Rodr\u00edguez R, Cavero-Redondo I, Pascual-Morena C, \u00c1lvarez-Bueno C, et al. Exercise during pregnancy for preventing gestational diabetes mellitus and hypertensive disorders: an umbrella review of randomised controlled trials and an updated meta-analysis. BJOG. 2023;130(3):264\u201375. https:\/\/doi.org\/10.1111\/1471-0528.17304.","journal-title":"BJOG"},{"issue":"6","key":"3247_CR10","doi-asserted-by":"publisher","first-page":"e13141","DOI":"10.1111\/ijn.13141","volume":"29","author":"X Yang","year":"2023","unstructured":"Yang X, Han R, Xiang Z, Li H, Zhao Q, Chen L, et al. Clinical practice guidelines on physical activity and exercise for pregnant women with gestational diabetes mellitus: a systematic review. Int J Nurs Pract. 2023;29(6):e13141. https:\/\/doi.org\/10.1111\/ijn.13141.","journal-title":"Int J Nurs Pract"},{"issue":"9","key":"3247_CR11","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/biomedicines12091975","volume":"12","author":"G Novelli","year":"2024","unstructured":"Novelli G, Calcaterra G, Casciani F, Pecorelli S, Mehta JL. \u2018Exerkines\u2019: a comprehensive term for the factors produced in response to exercise. Biomedicines. 2024;12(9):1975. https:\/\/doi.org\/10.3390\/biomedicines12091975.","journal-title":"Biomedicines"},{"key":"3247_CR12","doi-asserted-by":"publisher","first-page":"102816","DOI":"10.1016\/j.arr.2025.102816","volume":"110","author":"F Yu","year":"2025","unstructured":"Yu F, Zong B, Tian Z, Jia D, Wang R. Exerkines: potential regulators of diabetic cardiomyopathy. Ageing Res Rev. 2025;110:102816. https:\/\/doi.org\/10.1016\/j.arr.2025.102816.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"3247_CR13","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1111\/febs.16173","volume":"289","author":"SA Chae","year":"2022","unstructured":"Chae SA, Son JS, Du M. Prenatal exercise in fetal development: a placental perspective. FEBS J. 2022;289(11):3058\u201371. https:\/\/doi.org\/10.1111\/febs.16173.","journal-title":"FEBS J"},{"issue":"1","key":"3247_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12576-023-00885-1","volume":"73","author":"HA Pahlavani","year":"2023","unstructured":"Pahlavani HA, Laher I, Weiss K, Knechtle B, Zouhal H. Physical exercise for a healthy pregnancy: the role of placentokines and exerkines. J Physiol Sci. 2023;73(1):30. https:\/\/doi.org\/10.1186\/s12576-023-00885-1.","journal-title":"J Physiol Sci"},{"issue":"9","key":"3247_CR15","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3390\/jcm11092433","volume":"11","author":"MDM Roca-Rodr\u00edguez","year":"2022","unstructured":"Roca-Rodr\u00edguez MDM, Ramos-Garc\u00eda P, L\u00f3pez-Tinoco C, Aguilar-Diosdado M. Significance of serum-plasma leptin profile during pregnancy in gestational diabetes mellitus: a systematic review and meta-analysis. J Clin Med. 2022;11(9):2433. https:\/\/doi.org\/10.3390\/jcm11092433.","journal-title":"J Clin Med"},{"key":"3247_CR16","doi-asserted-by":"publisher","first-page":"154924","DOI":"10.1016\/j.cyto.2019.154924","volume":"126","author":"L Cui","year":"2020","unstructured":"Cui L, Qiao T, Xu F, Li Z, Chen T, Su H, et al. Circulating irisin levels of prenatal and postnatal patients with gestational diabetes mellitus: a systematic review and meta-analysis. Cytokine. 2020;126:154924. https:\/\/doi.org\/10.1016\/j.cyto.2019.154924.","journal-title":"Cytokine"},{"issue":"3","key":"3247_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/obr.12009","volume":"14","author":"JL Rourke","year":"2013","unstructured":"Rourke JL, Dranse HJ, Sinal CJ. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev. 2013;14(3):245\u201362. https:\/\/doi.org\/10.1111\/obr.12009.","journal-title":"Obes Rev"},{"issue":"1","key":"3247_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/1523-1747.ep12276660","volume":"109","author":"S Nagpal","year":"1997","unstructured":"Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Investig Dermatol. 1997;109(1):91\u20135. https:\/\/doi.org\/10.1111\/1523-1747.ep12276660.","journal-title":"J Investig Dermatol"},{"issue":"5","key":"3247_CR19","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I","volume":"28","author":"M Samson","year":"1998","unstructured":"Samson M, Edinger AL, Stordeur P, Rucker J, Verhasselt V, Sharron M, et al. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol. 1998;28(5):1689\u2013700.","journal-title":"Eur J Immunol"},{"issue":"3","key":"3247_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1530\/JOE-13-0106","volume":"219","author":"L Rouger","year":"2013","unstructured":"Rouger L, Denis GR, Luangsay S, Parmentier M. ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation. J Endocrinol. 2013;219(3):279\u201389. https:\/\/doi.org\/10.1530\/JOE-13-0106.","journal-title":"J Endocrinol"},{"issue":"8","key":"3247_CR21","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3390\/biomedicines10082018","volume":"10","author":"L Zhao","year":"2022","unstructured":"Zhao L, Leung LL, Morser J. Chemerin forms: their generation and activity. Biomedicines. 2022;10(8):2018. https:\/\/doi.org\/10.3390\/biomedicines10082018.","journal-title":"Biomedicines"},{"issue":"10","key":"3247_CR22","doi-asserted-by":"publisher","first-page":"e0164179","DOI":"10.1371\/journal.pone.0164179","volume":"11","author":"O De Henau","year":"2016","unstructured":"De Henau O, Degroot GN, Imbault V, Robert V, De Poorter C, Mcheik S, et al. Signaling properties of chemerin receptors CMKLR1, GPR1 and CCRL2. PLoS ONE. 2016;11(10):e0164179. https:\/\/doi.org\/10.1371\/journal.pone.0164179.","journal-title":"PLoS ONE"},{"issue":"2","key":"3247_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/JOE-14-0069","volume":"222","author":"JL Rourke","year":"2014","unstructured":"Rourke JL, Muruganandan S, Dranse HJ, McMullen NM, Sinal CJ. Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice. J Endocrinol. 2014;222(2):201\u201315. https:\/\/doi.org\/10.1530\/JOE-14-0069.","journal-title":"J Endocrinol"},{"issue":"9","key":"3247_CR24","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/prot.26348","volume":"90","author":"M Bufano","year":"2022","unstructured":"Bufano M, Laffranchi M, Sozzani S, Raimondo D, Silvestri R, Coluccia A. Exploring CCRL2 chemerin binding using accelerated molecular dynamics. Proteins. 2022;90(9):1714\u201320. https:\/\/doi.org\/10.1002\/prot.26348.","journal-title":"Proteins"},{"issue":"3","key":"3247_CR25","doi-asserted-by":"publisher","first-page":"qiae181","DOI":"10.1093\/jleuko\/qiae181","volume":"117","author":"M Laffranchi","year":"2025","unstructured":"Laffranchi M, Schioppa T, Sozio F, Piser\u00e0 A, Tiberio L, Salvi V, et al. Chemerin in immunity. J Leukoc Biol. 2025;117(3):qiae181. https:\/\/doi.org\/10.1093\/jleuko\/qiae181.","journal-title":"J Leukoc Biol."},{"issue":"7","key":"3247_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1515\/hsz-2021-0409","volume":"403","author":"TF Fischer","year":"2022","unstructured":"Fischer TF, Beck-Sickinger AG. Chemerin\u2014exploring a versatile adipokine. Biol Chem. 2022;403(7):625\u201342. https:\/\/doi.org\/10.1515\/hsz-2021-0409.","journal-title":"Biol Chem"},{"issue":"4","key":"3247_CR27","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/biomedicines12040924","volume":"12","author":"L Zhao","year":"2024","unstructured":"Zhao L, Zhou J, Abbasi F, Fathzadeh M, Knowles JW, Leung LLK, et al. Chemerin in participants with or without insulin resistance and diabetes. Biomedicines. 2024;12(4):924. https:\/\/doi.org\/10.3390\/biomedicines12040924.","journal-title":"Biomedicines"},{"issue":"10","key":"3247_CR28","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.21037\/tp-24-264","volume":"13","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gu C, Deng M, Yang L, Yang W. Circulating chemerin and interleukin-6 in children with obesity: possible metabolic risk predictors. Transl Pediatr. 2024;13(10):1760\u20136. https:\/\/doi.org\/10.21037\/tp-24-264.","journal-title":"Transl Pediatr."},{"issue":"3","key":"3247_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1590\/1806-9282.66.3.300","volume":"66","author":"VS Fontes","year":"2020","unstructured":"Fontes VS, Mateus K, Netto MP, Oliveira RMS, Machado-Coelho GLL, C\u00e2ndido APC. Analysis of the chemerin and resistin adipokines in children and adolescents. Rev Assoc Med Bras. 2020;66(3):300\u20136. https:\/\/doi.org\/10.1590\/1806-9282.66.3.300.","journal-title":"Rev Assoc Med Bras"},{"issue":"1","key":"3247_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jcp.25918","volume":"233","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Liu P, Jiao W, Meng J, Feng J. Gax suppresses chemerin\/CMKLR1-induced preadipocyte biofunctions through the inhibition of Akt\/mTOR and ERK signaling pathways. J Cell Physiol. 2018;233(1):572\u201386. https:\/\/doi.org\/10.1002\/jcp.25918.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3247_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12916-025-03891-9","volume":"23","author":"H Klein","year":"2025","unstructured":"Klein H, Zelicha H, Yaskolka Meir A, Rinott E, Tsaban G, Kaplan A, et al. Visceral adipose tissue area and proportion provide distinct reflections of cardiometabolic outcomes in weight loss; pooled analysis of MRI-assessed CENTRAL and DIRECT PLUS dietary randomized controlled trials. BMC Med. 2025;23(1):57. https:\/\/doi.org\/10.1186\/s12916-025-03891-9.","journal-title":"BMC Med"},{"issue":"24","key":"3247_CR32","doi-asserted-by":"publisher","first-page":"e13962","DOI":"10.14814\/phy2.13962","volume":"6","author":"N Nakamura","year":"2018","unstructured":"Nakamura N, Naruse K, Kobayashi Y, Miyabe M, Saiki T, Enomoto A, et al. Chemerin promotes angiogenesis in vivo. Physiol Rep. 2018;6(24):e13962. https:\/\/doi.org\/10.14814\/phy2.13962.","journal-title":"Physiol Rep."},{"key":"3247_CR33","doi-asserted-by":"publisher","first-page":"897105","DOI":"10.3389\/fphys.2022.897105","volume":"13","author":"H Yun","year":"2022","unstructured":"Yun H, Dumbell R, Hanna K, Bowen J, McLean SL, Kantamneni S, et al. The chemerin-CMKLR1 axis is functionally important for central regulation of energy homeostasis. Front Physiol. 2022;13:897105. https:\/\/doi.org\/10.3389\/fphys.2022.897105.","journal-title":"Front Physiol"},{"key":"3247_CR34","doi-asserted-by":"publisher","first-page":"26830","DOI":"10.1038\/srep26830","volume":"6","author":"G Helfer","year":"2016","unstructured":"Helfer G, Ross AW, Thomson LM, Mayer CD, Stoney PN, McCaffery PJ, et al. A neuroendocrine role for chemerin in hypothalamic remodelling and photoperiodic control of energy balance. Sci Rep. 2016;6:26830. https:\/\/doi.org\/10.1038\/srep26830.","journal-title":"Sci Rep"},{"issue":"5","key":"3247_CR35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/jcmm.12487","volume":"19","author":"Q Xie","year":"2015","unstructured":"Xie Q, Deng Y, Huang C, Liu P, Yang Y, Shen W, et al. Chemerin-induced mitochondrial dysfunction in skeletal muscle. J Cell Mol Med. 2015;19(5):986\u201395. https:\/\/doi.org\/10.1111\/jcmm.12487.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"3247_CR36","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/biomedicines13061481","volume":"13","author":"AM Imiela","year":"2025","unstructured":"Imiela AM, St\u0119pnicki J, Zawadzka PS, Bursa A, Pruszczyk P. Chemerin as a driver of cardiovascular diseases: new perspectives and future directions. Biomedicines. 2025;13(6):1481. https:\/\/doi.org\/10.3390\/biomedicines13061481.","journal-title":"Biomedicines"},{"key":"3247_CR37","doi-asserted-by":"publisher","first-page":"152321","DOI":"10.1016\/j.bbrc.2025.152321","volume":"778","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Yang Z. Reduction of serum lipids by liver-specific knockout of chemerin in DIO mice. Biochem Biophys Res Commun. 2025;778:152321. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3247_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12944-020-01378-5","volume":"19","author":"J Jia","year":"2020","unstructured":"Jia J, Yu F, Xiong Y, Wei W, Ma H, Nisi F, et al. Chemerin enhances the adhesion and migration of human endothelial progenitor cells and increases lipid accumulation in mice with atherosclerosis. Lipids Health Dis. 2020;19(1):207. https:\/\/doi.org\/10.1186\/s12944-020-01378-5.","journal-title":"Lipids Health Dis"},{"issue":"17","key":"3247_CR39","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/cvr\/cvad164","volume":"119","author":"AWC Man","year":"2023","unstructured":"Man AWC, Zhou Y, Reifenberg G, Camp A, M\u00fcnzel T, Daiber A, et al. Deletion of adipocyte NOS3 potentiates high-fat diet-induced hypertension and vascular remodelling via chemerin. Cardiovasc Res. 2023;119(17):2755\u201369. https:\/\/doi.org\/10.1093\/cvr\/cvad164.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3247_CR40","doi-asserted-by":"publisher","first-page":"14171","DOI":"10.1038\/s41598-017-14518-2","volume":"7","author":"J Menzel","year":"2017","unstructured":"Menzel J, di Giuseppe R, Biemann R, Wittenbecher C, Aleksandrova K, Eichelmann F, et al. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci Rep. 2017;7(1):14171. https:\/\/doi.org\/10.1038\/s41598-017-14518-2.","journal-title":"Sci Rep"},{"issue":"15","key":"3247_CR41","doi-asserted-by":"publisher","first-page":"e012091","DOI":"10.1161\/JAHA.119.012091","volume":"8","author":"X Zhou","year":"2019","unstructured":"Zhou X, Tao Y, Chen Y, Xu W, Qian Z, Lu X. Serum Chemerin as a novel prognostic indicator in chronic heart failure. J Am Heart Assoc. 2019;8(15):e012091. https:\/\/doi.org\/10.1161\/JAHA.119.012091.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"3247_CR42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/labmed\/lmac059","volume":"53","author":"A Ismaiel","year":"2022","unstructured":"Ismaiel A, Ashfaq MZ, Leucuta DC, Ismaiel M, Ensar Ismaiel D, Popa SL, et al. Chemerin levels in acute coronary syndrome: systematic review and meta-analysis. Lab Med. 2022;53(6):552\u201360. https:\/\/doi.org\/10.1093\/labmed\/lmac059.","journal-title":"Lab Med"},{"issue":"5","key":"3247_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.placenta.2012.02.007","volume":"33","author":"MF Garces","year":"2012","unstructured":"Garces MF, Sanchez E, Acosta BJ, Angel E, Ru\u00edz AI, Rubio-Romero JA, et al. Expression and regulation of chemerin during rat pregnancy. Placenta. 2012;33(5):373\u20138. https:\/\/doi.org\/10.1016\/j.placenta.2012.02.007.","journal-title":"Placenta"},{"key":"3247_CR44","doi-asserted-by":"publisher","first-page":"123645","DOI":"10.1016\/j.lfs.2025.123645","volume":"373","author":"J Cai","year":"2025","unstructured":"Cai J, Han X, Peng S, Chen J, Zhang JV, Huang C. Chemerin facilitates placental trophoblast invasion and spiral artery remodeling through the pentose phosphate pathway. Life Sci. 2025;373:123645. https:\/\/doi.org\/10.1016\/j.lfs.2025.123645.","journal-title":"Life Sci"},{"issue":"1","key":"3247_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12915-025-02294-9","volume":"23","author":"JX Cai","year":"2025","unstructured":"Cai JX, Le AW, Han XY, Chen J, Lei XH, Huang C, et al. Chemerin sustains the growth of spongiotrophoblast and sinusoidal trophoblast giant cells through fatty acid oxidation. BMC Biol. 2025;23(1):199. https:\/\/doi.org\/10.1186\/s12915-025-02294-9.","journal-title":"BMC Biol"},{"key":"3247_CR46","doi-asserted-by":"publisher","first-page":"883636","DOI":"10.3389\/fcell.2022.883636","volume":"10","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Xiao Z, Lee CL, Duan YG, Fan X, Yeung WSB, et al. The regulatory roles of chemerin-chemokine-like receptor 1 axis in placental development and vascular remodeling during early pregnancy. Front Cell Dev Biol. 2022;10:883636. https:\/\/doi.org\/10.3389\/fcell.2022.883636.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3247_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s11684-017-0577-9","volume":"12","author":"X Yang","year":"2018","unstructured":"Yang X, Yao J, Wei Q, Ye J, Yin X, Quan X, et al. Role of chemerin\/CMKLR1 in the maintenance of early pregnancy. Front Med. 2018;12(5):525\u201332. https:\/\/doi.org\/10.1007\/s11684-017-0577-9.","journal-title":"Front Med"},{"issue":"3","key":"3247_CR48","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1515\/jpm-2013-0166","volume":"42","author":"M Kasher-Meron","year":"2014","unstructured":"Kasher-Meron M, Mazaki-Tovi S, Barhod E, Hemi R, Haas J, Gat I, et al. Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy. J Perinat Med. 2014;42(3):371\u20138. https:\/\/doi.org\/10.1515\/jpm-2013-0166.","journal-title":"J Perinat Med"},{"key":"3247_CR49","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2147\/DMSO.S417632","volume":"16","author":"Z Ma","year":"2023","unstructured":"Ma Z, Chu L, Zhang Y, Lu F, Zhu Y, Wu F, et al. Is chemerin associated with gestational diabetes mellitus? A case-control study. Diabetes Metab Syndr Obes. 2023;16:2271\u201381. https:\/\/doi.org\/10.2147\/DMSO.S417632.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"3247_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12944-018-0826-1","volume":"17","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Chen H, Ju H, Sun M. Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis. Lipids Health Dis. 2018;17(1):169. https:\/\/doi.org\/10.1186\/s12944-018-0826-1.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"3247_CR51","doi-asserted-by":"publisher","first-page":"E987","DOI":"10.1152\/ajpendo.00437.2018","volume":"316","author":"B Huang","year":"2019","unstructured":"Huang B, Huang C, Zhao H, Zhu W, Wang B, Wang H, et al. Impact of GPR1 signaling on maternal high-fat feeding and placenta metabolism in mice. Am J Physiol Endocrinol Metab. 2019;316(6):E987\u201397. https:\/\/doi.org\/10.1152\/ajpendo.00437.2018.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"3247_CR52","doi-asserted-by":"publisher","first-page":"e22806","DOI":"10.1096\/fj.202201611R","volume":"37","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhang H, Jiang Y, Wei L, Chen Y, Zhang J, et al. The role of chemerin in the regulation of cGAS-STING pathway in gestational diabetes mellitus placenta. FASEB J. 2023;37(3):e22806. https:\/\/doi.org\/10.1096\/fj.202201611R.","journal-title":"FASEB J"},{"issue":"1","key":"3247_CR53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-019-1573-6","volume":"16","author":"Z Liang","year":"2019","unstructured":"Liang Z, Han L, Sun D, Chen Y, Wu Q, Zhang L, et al. Chemerin-induced macrophages pyroptosis in fetal brain tissue leads to cognitive disorder in offspring of diabetic dams. J Neuroinflam. 2019;16(1):226. https:\/\/doi.org\/10.1186\/s12974-019-1573-6.","journal-title":"J Neuroinflam"},{"issue":"1","key":"3247_CR54","doi-asserted-by":"publisher","first-page":"e001333","DOI":"10.1136\/bmjdrc-2020-001333","volume":"8","author":"EC Francis","year":"2020","unstructured":"Francis EC, Li M, Hinkle SN, Cao Y, Chen J, Wu J, et al. Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort. BMJ Open Diabetes Res Care. 2020;8(1):e001333. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001333.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"14","key":"3247_CR55","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.3390\/ijms26146622","volume":"26","author":"H Aldharee","year":"2025","unstructured":"Aldharee H, Makki YR, Hamdan HZ. The association between chemerin levels and gestational diabetes mellitus: an updated systematic review and meta-analysis. Int J Mol Sci. 2025;26(14):6622. https:\/\/doi.org\/10.3390\/ijms26146622.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3247_CR56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12944-023-01941-w","volume":"22","author":"Y Yin","year":"2023","unstructured":"Yin Y, Xie S, Xu Q, Liao L, Chen H, Zhou R. Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis. Lipids Health Dis. 2023;22(1):179. https:\/\/doi.org\/10.1186\/s12944-023-01941-w.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"3247_CR57","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1080\/13813455.2021.1892149","volume":"129","author":"D Ashtary-Larky","year":"2023","unstructured":"Ashtary-Larky D, Kashkooli S, Bagheri R, Lamuchi-Deli N, Alipour M, Mombaini D, et al. The effect of exercise training on serum concentrations of chemerin in patients with metabolic diseases: a systematic review and meta-analysis. Arch Physiol Biochem. 2023;129(5):1028\u201337. https:\/\/doi.org\/10.1080\/13813455.2021.1892149.","journal-title":"Arch Physiol Biochem"},{"issue":"3","key":"3247_CR58","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/dom.1612","volume":"27","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Jia Y, Guo Y, Yu X, Wang R, Wang X. Chemerin loss-of-function attenuates glucagon-like peptide-1 secretion in exercised obese mice. Diabetes Obes Metab. 2025;27(3):1296\u2013313. https:\/\/doi.org\/10.1111\/dom.1612.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"3247_CR59","doi-asserted-by":"publisher","first-page":"159409","DOI":"10.1016\/j.bbalip.2023.159409","volume":"1868","author":"X Lin","year":"2023","unstructured":"Lin X, Qu J, Yin L, Wang R, Wang X. Aerobic exercise-induced decrease of chemerin improved glucose and lipid metabolism and fatty liver of diabetes mice through key metabolism enzymes and proteins. Biochimica et Biophysica Acta (BBA) Mol Cell Biol Lipids. 2023;1868(12):159409. https:\/\/doi.org\/10.1016\/j.bbalip.2023.159409.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Cell Biol Lipids"},{"issue":"3","key":"3247_CR60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1556\/2060.2021.00182","volume":"108","author":"F Ahmadabadi","year":"2021","unstructured":"Ahmadabadi F, Nakhaei H, Mogharnasi M, Huang CJ. Aerobic interval training improves irisin and chemerin levels of both liver and visceral adipose tissues and circulating asprosin in rats with metabolic syndrome. Physiol Int. 2021;108(3):383\u201397. https:\/\/doi.org\/10.1556\/2060.2021.00182.","journal-title":"Physiol Int"},{"key":"3247_CR61","doi-asserted-by":"publisher","unstructured":"Phan P, Ternier G, Edirisinghe O, Kumar TKS. Exploring endocrine FGFs - structures, functions and biomedical applications. Int J Biochem Mol Biol. 2024;15(4):68\u201399. https:\/\/doi.org\/10.62347\/PALK2137.","DOI":"10.62347\/PALK2137"},{"issue":"6","key":"3247_CR62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5(6):415\u201325. https:\/\/doi.org\/10.1016\/j.cmet.2007.05.003.","journal-title":"Cell Metab"},{"key":"3247_CR63","doi-asserted-by":"publisher","first-page":"101303","DOI":"10.1016\/j.plipres.2024.101303","volume":"96","author":"A Fougerat","year":"2024","unstructured":"Fougerat A, Bruse J, Polizzi A, Montagner A, Guillou H, Wahli W. Lipid sensing by PPAR\u03b1: role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting. Prog Lipid Res. 2024;96:101303. https:\/\/doi.org\/10.1016\/j.plipres.2024.101303.","journal-title":"Prog Lipid Res"},{"issue":"2","key":"3247_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.celrep.2017.09.065","volume":"21","author":"A Iroz","year":"2017","unstructured":"Iroz A, Montagner A, Benhamed F, Levavasseur F, Polizzi A, Anthony E, et al. A specific ChREBP and PPAR\u03b1 cross-talk is required for the glucose-mediated FGF21 response. Cell Rep. 2017;21(2):403\u201316. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.065.","journal-title":"Cell Rep"},{"issue":"3","key":"3247_CR65","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PA Dutchak","year":"2012","unstructured":"Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ, et al. Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones. Cell. 2012;148(3):556\u201367. https:\/\/doi.org\/10.1016\/j.cell.2011.11.062.","journal-title":"Cell"},{"issue":"1","key":"3247_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7150\/ijbs.73936","volume":"19","author":"H Tan","year":"2023","unstructured":"Tan H, Yue T, Chen Z, Wu W, Xu S, Weng J. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine. Int J Biol Sci. 2023;19(1):66\u201388. https:\/\/doi.org\/10.7150\/ijbs.73936.","journal-title":"Int J Biol Sci"},{"issue":"28","key":"3247_CR67","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.1006962107","volume":"107","author":"MD Chau","year":"2010","unstructured":"Chau MD, Gao J, Yang Q, Wu Z, Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc Natl Acad Sci U S A. 2010;107(28):12553\u20138. https:\/\/doi.org\/10.1073\/pnas.1006962107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3247_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/a-1778-4159","volume":"54","author":"E Szczepa\u0144ska","year":"2022","unstructured":"Szczepa\u0144ska E, Gietka-Czernel M. FGF21: a novel regulator of glucose and lipid metabolism and whole-body energy balance. Horm Metab Res. 2022;54(4):203\u201311. https:\/\/doi.org\/10.1055\/a-1778-4159.","journal-title":"Horm Metab Res"},{"issue":"5","key":"3247_CR69","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1053\/j.gastro.2014.07.044","volume":"147","author":"FM Fisher","year":"2014","unstructured":"Fisher FM, Chui PC, Nasser IA, Popov Y, Cunniff JC, Lundasen T, et al. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology. 2014;147(5):1073-83.e6. https:\/\/doi.org\/10.1053\/j.gastro.2014.07.044.","journal-title":"Gastroenterology"},{"issue":"2","key":"3247_CR70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2020.06.008","volume":"32","author":"SO Jensen-Cody","year":"2020","unstructured":"Jensen-Cody SO, Flippo KH, Claflin KE, Yavuz Y, Sapouckey SA, Walters GC, et al. FGF21 signals to glutamatergic neurons in the ventromedial hypothalamus to suppress carbohydrate intake. Cell Metab. 2020;32(2):273-286.e6. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.008.","journal-title":"Cell Metab"},{"issue":"2","key":"3247_CR71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cmet.2015.12.008","volume":"23","author":"S Talukdar","year":"2016","unstructured":"Talukdar S, Owen BM, Song P, Hernandez G, Zhang Y, Zhou Y, et al. FGF21 regulates sweet and alcohol preference. Cell Metab. 2016;23(2):344\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.008.","journal-title":"Cell Metab"},{"key":"3247_CR72","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.molmet.2024.102068","volume":"91","author":"MSH Khan","year":"2025","unstructured":"Khan MSH, Kim SQ, Ross RC, Corpodean F, Spann RA, Albarado DA, et al. FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signaling. Mol Metab. 2025;91:102068. https:\/\/doi.org\/10.1016\/j.molmet.2024.102068.","journal-title":"Mol Metab"},{"issue":"3","key":"3247_CR73","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jeab.745","volume":"117","author":"F Torres","year":"2022","unstructured":"Torres F, Khan S, Fernandez-Kim SO, Spann R, Albarado D, Wagner TJ, et al. Dynamic effects of dietary protein restriction on body weights, food consumption, and protein preference in C57BL\/6J and Fgf21-KO mice. J Exp Anal Behav. 2022;117(3):346\u201362. https:\/\/doi.org\/10.1002\/jeab.745.","journal-title":"J Exp Anal Behav"},{"issue":"7","key":"3247_CR74","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cmet.2025.04.014","volume":"37","author":"JP Rose","year":"2025","unstructured":"Rose JP, Morgan DA, Sullivan AI, Fu X, Inigo-Vollmer M, Burgess SC, et al. FGF21 reverses MASH through coordinated actions on the CNS and liver. Cell Metab. 2025;37(7):1515-1529.e6. https:\/\/doi.org\/10.1016\/j.cmet.2025.04.014.","journal-title":"Cell Metab"},{"issue":"21","key":"3247_CR75","doi-asserted-by":"publisher","first-page":"e1900088","DOI":"10.1002\/mnfr.201900088","volume":"63","author":"RC Zapata","year":"2019","unstructured":"Zapata RC, Singh A, Pezeshki A, Avirineni BS, Patra S, Chelikani PK. Low-protein diets with fixed carbohydrate content promote hyperphagia and sympathetically mediated increase in energy expenditure. Mol Nutr Food Res. 2019;63(21):e1900088. https:\/\/doi.org\/10.1002\/mnfr.201900088.","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"3247_CR76","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","volume":"17","author":"Z Lin","year":"2013","unstructured":"Lin Z, Tian H, Lam KS, Lin S, Hoo RC, Konishi M, et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 2013;17(5):779\u201389. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.005.","journal-title":"Cell Metab"},{"issue":"7","key":"3247_CR77","doi-asserted-by":"publisher","first-page":"101629","DOI":"10.1016\/j.xcrm.2024.101629","volume":"5","author":"M Fiorenza","year":"2024","unstructured":"Fiorenza M, Checa A, Sandsdal RM, Jensen SBK, Juhl CR, Noer MH, et al. Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids. Cell Rep Med. 2024;5(7):101629. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101629.","journal-title":"Cell Rep Med"},{"issue":"2","key":"3247_CR78","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s44318-023-00008-x","volume":"43","author":"CF Chang","year":"2024","unstructured":"Chang CF, Gunawan AL, Liparulo I, Zushin PH, Vitangcol K, Timblin GA, et al. Brown adipose tissue CoQ deficiency activates the integrated stress response and FGF21-dependent mitohormesis. EMBO J. 2024;43(2):168\u201395. https:\/\/doi.org\/10.1038\/s44318-023-00008-x.","journal-title":"EMBO J"},{"issue":"10","key":"3247_CR79","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1016\/j.celrep.2020.02.055","volume":"30","author":"TD Challa","year":"2020","unstructured":"Challa TD, Dapito DH, Kulenkampff E, Kiehlmann E, Moser C, Straub L, et al. A genetic model to study the contribution of brown and brite adipocytes to metabolism. Cell Rep. 2020;30(10):3424-3433.e4. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.055.","journal-title":"Cell Rep"},{"key":"3247_CR80","doi-asserted-by":"publisher","first-page":"116042","DOI":"10.1016\/j.bcp.2024.116042","volume":"221","author":"S Stanic","year":"2024","unstructured":"Stanic S, Bardova K, Janovska P, Rossmeisl M, Kopecky J, Zouhar P. Prolonged FGF21 treatment increases energy expenditure and induces weight loss in obese mice independently of UCP1 and adrenergic signaling. Biochem Pharmacol. 2024;221:116042. https:\/\/doi.org\/10.1016\/j.bcp.2024.116042.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3247_CR81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.177857.111","volume":"26","author":"FM Fisher","year":"2012","unstructured":"Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, et al. FGF21 regulates PGC-1\u03b1 and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26(3):271\u201381. https:\/\/doi.org\/10.1101\/gad.177857.111.","journal-title":"Genes Dev"},{"issue":"19","key":"3247_CR82","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1042\/CS20190093","volume":"133","author":"T Xie","year":"2019","unstructured":"Xie T, So WY, Li XY, Leung PS. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic \u03b2-cell dysfunction via regulation of AMPK signaling and lipid metabolism. Clin Sci (Lond). 2019;133(19):2029\u201344. https:\/\/doi.org\/10.1042\/CS20190093.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"3247_CR83","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/dom.16089","volume":"27","author":"M Moreno-Lopez","year":"2025","unstructured":"Moreno-Lopez M, Louvet I, Delalleau N, Acosta-Montalvo A, Thevenet J, Pasquetti G, et al. The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition. Diabetes Obes Metab. 2025;27(2):885\u201398. https:\/\/doi.org\/10.1111\/dom.16089.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"3247_CR84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/JME-19-0210","volume":"65","author":"G Rosales-Soto","year":"2020","unstructured":"Rosales-Soto G, Diaz-Vegas A, Casas M, Contreras-Ferrat A, Jaimovich E. Fibroblast growth factor-21 potentiates glucose transport in skeletal muscle fibers. J Mol Endocrinol. 2020;65(3):85\u201395. https:\/\/doi.org\/10.1530\/JME-19-0210.","journal-title":"J Mol Endocrinol"},{"issue":"Pt 5","key":"3247_CR85","doi-asserted-by":"publisher","first-page":"136911","DOI":"10.1016\/j.ijbiomac.2024.136911","volume":"282","author":"QY Zhang","year":"2024","unstructured":"Zhang QY, Liu HX. Insights into the role of FGF21 in coronary heart disease. Int J Biol Macromol. 2024;282(Pt 5):136911. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136911.","journal-title":"Int J Biol Macromol"},{"key":"3247_CR86","doi-asserted-by":"publisher","first-page":"1202730","DOI":"10.3389\/fcvm.2023.1202730","volume":"10","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Cui X, Liao Z. Mechanism of fibroblast growth factor 21 in cardiac remodeling. Front Cardiovasc Med. 2023;10:1202730. https:\/\/doi.org\/10.3389\/fcvm.2023.1202730.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3247_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/path.5226","volume":"248","author":"G Ferrer-Curriu","year":"2019","unstructured":"Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, et al. Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease. J Pathol. 2019;248(1):30\u201340. https:\/\/doi.org\/10.1002\/path.5226.","journal-title":"J Pathol"},{"issue":"6","key":"3247_CR88","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","volume":"1865","author":"S Li","year":"2019","unstructured":"Li S, Zhu Z, Xue M, Yi X, Liang J, Niu C, et al. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1241\u201352. https:\/\/doi.org\/10.1016\/j.bbadis.2019.01.019.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"3247_CR89","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-025-56885-9","volume":"16","author":"K Zhang","year":"2025","unstructured":"Zhang K, Gan J, Wang B, Lei W, Zhen D, Yang J, et al. FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. Nat Commun. 2025;16(1):1661. https:\/\/doi.org\/10.1038\/s41467-025-56885-9.","journal-title":"Nat Commun"},{"issue":"3","key":"3247_CR90","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","volume":"81","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Rolph T, Knott M, Dubourg J. FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond. J Hepatol. 2024;81(3):562\u201376. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.034.","journal-title":"J Hepatol"},{"issue":"8","key":"3247_CR91","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/ueg2.12534","volume":"12","author":"R Gallego-Dur\u00e1n","year":"2024","unstructured":"Gallego-Dur\u00e1n R, Ampuero J, Maya-Miles D, Pastor-Ram\u00edrez H, Montero-Vallejo R, Rivera-Esteban J, et al. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression. United European Gastroenterol J. 2024;12(8):1056\u201368. https:\/\/doi.org\/10.1002\/ueg2.12534.","journal-title":"United European Gastroenterol J"},{"issue":"3","key":"3247_CR92","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00125-014-3458-7","volume":"58","author":"KL Ong","year":"2015","unstructured":"Ong KL, Januszewski AS, O\u2019Connell R, Jenkins AJ, Xu A, Sullivan DR, et al. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015;58(3):464\u201373. https:\/\/doi.org\/10.1007\/s00125-014-3458-7.","journal-title":"Diabetologia"},{"key":"3247_CR93","doi-asserted-by":"publisher","first-page":"155535","DOI":"10.1016\/j.metabol.2023.155535","volume":"143","author":"W Tucker","year":"2023","unstructured":"Tucker W, McClelland RL, Allison MA, Szklo M, Rye KA, Ong KL. The association of circulating fibroblast growth factor 21 levels with incident heart failure: the multi-ethnic study of atherosclerosis. Metabolism. 2023;143:155535. https:\/\/doi.org\/10.1016\/j.metabol.2023.155535.","journal-title":"Metabolism"},{"key":"3247_CR94","doi-asserted-by":"publisher","first-page":"705273","DOI":"10.3389\/fcvm.2021.705273","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yan J, Yang N, Qian Z, Nie H, Yang Z, et al. High-level serum fibroblast growth factor 21 concentration is closely associated with an increased risk of cardiovascular diseases: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:705273. https:\/\/doi.org\/10.3389\/fcvm.2021.705273.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"3247_CR95","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.tem.2024.02.001","volume":"35","author":"ZSW Chui","year":"2024","unstructured":"Chui ZSW, Shen Q, Xu A. Current status and future perspectives of FGF21 analogues in clinical trials. Trends Endocrinol Metab. 2024;35(5):371\u201384. https:\/\/doi.org\/10.1016\/j.tem.2024.02.001.","journal-title":"Trends Endocrinol Metab"},{"key":"3247_CR96","doi-asserted-by":"publisher","first-page":"9943228","DOI":"10.1155\/ije\/9943228","volume":"2025","author":"Z Nie","year":"2025","unstructured":"Nie Z, Xu J, Liu Y, Cao Q, Qiu X, Su Y, et al. Effects and safety of FGF21 analogs on glycemic parameters, lipid profiles, and adiponectin in overweight and obese adults: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2025;2025:9943228. https:\/\/doi.org\/10.1155\/ije\/9943228.","journal-title":"Int J Endocrinol"},{"issue":"7","key":"3247_CR97","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","volume":"27","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, Ruane PJ, Freilich BL, Neff G, Patil R, Behling CA, et al. Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. Nat Med. 2021;27(7):1262\u201371. https:\/\/doi.org\/10.1038\/s41591-021-01425-3.","journal-title":"Nat Med"},{"issue":"24","key":"3247_CR98","doi-asserted-by":"publisher","first-page":"17298","DOI":"10.3390\/ijms242417298","volume":"24","author":"A Sadowska","year":"2023","unstructured":"Sadowska A, Poniedzia\u0142ek-Czajkowska E, Mierzy\u0144ski R. The role of the FGF19 family in the pathogenesis of gestational diabetes: a narrative review. Int J Mol Sci. 2023;24(24):17298. https:\/\/doi.org\/10.3390\/ijms242417298.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3247_CR99","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/jdi.13889","volume":"13","author":"X Jia","year":"2022","unstructured":"Jia X, Bai L, Ma N, Lu Q. The relationship between serum adipokine fibroblast growth factor-21 and gestational diabetes mellitus. J Diabetes Investig. 2022;13(12):2047\u201353. https:\/\/doi.org\/10.1111\/jdi.13889.","journal-title":"J Diabetes Investig"},{"key":"3247_CR100","doi-asserted-by":"publisher","first-page":"4024877","DOI":"10.1155\/2023\/4024877","volume":"2023","author":"K Gawlik","year":"2023","unstructured":"Gawlik K, Milewicz T, Pawlica-Gosiewska D, Trznadel-Morawska I, Solnica B. Fibroblast growth factor 21 in gestational diabetes mellitus and type 2 diabetes mellitus. J Diabetes Res. 2023;2023:4024877. https:\/\/doi.org\/10.1155\/2023\/4024877.","journal-title":"J Diabetes Res"},{"key":"3247_CR101","doi-asserted-by":"publisher","first-page":"630287","DOI":"10.3389\/fendo.2021.630287","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Yuan M, Xu C, Zhang Y, Ying C, Xiao X. FGF21 serum levels in the early second trimester are positively correlated with the risk of subsequent gestational diabetes mellitus: a propensity-matched nested case-control study. Front Endocrinol (Lausanne). 2021;12:630287. https:\/\/doi.org\/10.3389\/fendo.2021.630287.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3247_CR102","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1507\/endocrj.EJ20-0481","volume":"68","author":"J Jia","year":"2021","unstructured":"Jia J, Wei W, Yu F, Liu R, Shen Y, Zhang R, et al. Circulating levels of fibroblast growth factor 21 in gestational diabetes mellitus: a meta-analysis. Endocr J. 2021;68(3):345\u201352. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0481.","journal-title":"Endocr J"},{"issue":"1","key":"3247_CR103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12884-025-07157-3","volume":"25","author":"Z Cao","year":"2025","unstructured":"Cao Z, Deng Z, Lu J, Yuan Y. Circulating fibroblast growth factor 21 levels in gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025;25(1):34. https:\/\/doi.org\/10.1186\/s12884-025-07157-3.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"3247_CR104","doi-asserted-by":"publisher","first-page":"167329","DOI":"10.1016\/j.bbadis.2024.167329","volume":"1870","author":"C Sun","year":"2024","unstructured":"Sun C, Wang L, Huang H, Zheng Z, Xu X, Wang H, et al. Mitigation of gestational diabetes-induced endothelial dysfunction through FGF21-NRF2 pathway activation involving L-Cystine. Biochimica et Biophysica Acta (BBA) Mol Basis Dis. 2024;1870(7):167329. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167329.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Dis"},{"issue":"22","key":"3247_CR105","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3390\/nu16223826","volume":"16","author":"L Hua","year":"2024","unstructured":"Hua L, Yang Y, Zhang H, Jiang X, Jin C, Feng B, et al. Adipocyte FGF21 signaling defect aggravated adipose tissue inflammation in gestational diabetes mellitus. Nutrients. 2024;16(22):3826. https:\/\/doi.org\/10.3390\/nu16223826.","journal-title":"Nutrients"},{"issue":"6","key":"3247_CR106","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1530\/EJE-19-0658","volume":"181","author":"FB Kampmann","year":"2019","unstructured":"Kampmann FB, Thuesen ACB, Hjort L, Bjerregaard AA, Chavarro JE, Frystyk J, et al. Increased leptin, decreased adiponectin and FGF21 concentrations in adolescent offspring of women with gestational diabetes. Eur J Endocrinol. 2019;181(6):691\u2013700. https:\/\/doi.org\/10.1530\/EJE-19-0658.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"3247_CR107","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.tem.2021.08.008","volume":"32","author":"S Keipert","year":"2021","unstructured":"Keipert S, Ost M. Stress-induced FGF21 and GDF15 in obesity and obesity resistance. Trends Endocrinol Metab. 2021;32(11):904\u201315. https:\/\/doi.org\/10.1016\/j.tem.2021.08.008.","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"3247_CR108","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.3390\/ijms24087284","volume":"24","author":"H Kim","year":"2023","unstructured":"Kim H, Jung J, Park S, Joo Y, Lee S, Sim J, et al. Exercise-induced fibroblast growth factor-21: a systematic review and meta-analysis. Int J Mol Sci. 2023;24(8):7284. https:\/\/doi.org\/10.3390\/ijms24087284.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3247_CR109","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.celrep.2019.02.014","volume":"26","author":"L Geng","year":"2019","unstructured":"Geng L, Liao B, Jin L, Huang Z, Triggle CR, Ding H, et al. Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues. Cell Rep. 2019;26(10):2738-2752.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.014.","journal-title":"Cell Rep"},{"issue":"1","key":"3247_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01541-3","volume":"17","author":"S Moharamzadeh","year":"2025","unstructured":"Moharamzadeh S, Kashef M, Salehpour M, Torabi M, Vesali S, Samsonchi Z, et al. Effects of exercise intensity and diet on cardiac tissue structure and FGF21\/\u03b2-Klotho signaling in type 2 diabetic mice: a comparative study of HFD and HFD\u2009+\u2009STZ induced type 2 diabetes models in mice. Diabetol Metab Syndr. 2025;17(1):4. https:\/\/doi.org\/10.1186\/s13098-024-01541-3.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3247_CR111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s42000-020-00245-3","volume":"20","author":"M Khalafi","year":"2021","unstructured":"Khalafi M, Alamdari KA, Symonds ME, Nobari H, Carlos-Vivas J. Impact of acute exercise on immediate and following early post-exercise FGF-21 concentration in adults: systematic review and meta-analysis. Hormones Athens. 2021;20(1):23\u201333. https:\/\/doi.org\/10.1007\/s42000-020-00245-3.","journal-title":"Hormones Athens"},{"issue":"10","key":"3247_CR112","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1139\/apnm-2018-0818","volume":"44","author":"SA Willis","year":"2019","unstructured":"Willis SA, Sargeant JA, Thackray AE, Yates T, Stensel DJ, Aithal GP, et al. Effect of exercise intensity on circulating hepatokine concentrations in healthy men. Appl Physiol Nutr Metab. 2019;44(10):1065\u201372. https:\/\/doi.org\/10.1139\/apnm-2018-0818.","journal-title":"Appl Physiol Nutr Metab"},{"key":"3247_CR113","doi-asserted-by":"publisher","first-page":"155137","DOI":"10.1016\/j.metabol.2022.155137","volume":"129","author":"M Porflitt-Rodr\u00edguez","year":"2022","unstructured":"Porflitt-Rodr\u00edguez M, Guzm\u00e1n-Arriagada V, Sandoval-Valderrama R, Tam CS, Pavicic F, Ehrenfeld P, et al. Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review. Metabolism. 2022;129:155137. https:\/\/doi.org\/10.1016\/j.metabol.2022.155137.","journal-title":"Metabolism"},{"issue":"4","key":"3247_CR114","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/17461391.2020.1762755","volume":"21","author":"F Shabkhiz","year":"2021","unstructured":"Shabkhiz F, Khalafi M, Rosenkranz S, Karimi P, Moghadami K. Resistance training attenuates circulating FGF-21 and myostatin and improves insulin resistance in elderly men with and without type 2 diabetes mellitus: a randomised controlled clinical trial. Eur J Sport Sci. 2021;21(4):636\u201345. https:\/\/doi.org\/10.1080\/17461391.2020.1762755.","journal-title":"Eur J Sport Sci"},{"issue":"1","key":"3247_CR115","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41440-024-01991-2","volume":"48","author":"M Shan","year":"2025","unstructured":"Shan M, Qiu F, Li P, Zhang Y, Shi L. Maternal exercise represses FGF21 via SIRT1 to improve the phenotypic transformation of vascular smooth muscle in hypertensive offspring. Hypertens Res. 2025;48(1):353\u201365. https:\/\/doi.org\/10.1038\/s41440-024-01991-2.","journal-title":"Hypertens Res"},{"issue":"2","key":"3247_CR116","doi-asserted-by":"publisher","first-page":"E203","DOI":"10.1152\/ajpendo.00076.2017","volume":"313","author":"N Chukijrungroat","year":"2017","unstructured":"Chukijrungroat N, Khamphaya T, Weerachayaphorn J, Songserm T, Saengsirisuwan V. Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver. Am J Physiol Endocrinol Metab. 2017;313(2):E203\u201312. https:\/\/doi.org\/10.1152\/ajpendo.00076.2017.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3247_CR117","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12967-016-0821-0","volume":"14","author":"D Guan","year":"2016","unstructured":"Guan D, Zhao L, Chen D, Yu B, Yu J. Regulation of fibroblast growth factor 15\/19 and 21 on metabolism: in the fed or fasted state. J Transl Med. 2016;14:63. https:\/\/doi.org\/10.1186\/s12967-016-0821-0.","journal-title":"J Transl Med"},{"issue":"6","key":"3247_CR118","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cmet.2013.04.007","volume":"17","author":"L Vergnes","year":"2013","unstructured":"Vergnes L, Lee JM, Chin RG, Auwerx J, Reue K. Diet1 functions in the FGF15\/19 enterohepatic signaling axis to modulate bile acid and lipid levels. Cell Metab. 2013;17(6):916\u201328. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.007.","journal-title":"Cell Metab"},{"issue":"3","key":"3247_CR119","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/joim.13767","volume":"295","author":"X Li","year":"2024","unstructured":"Li X, Lu W, Kharitonenkov A, Luo Y. Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. J Intern Med. 2024;295(3):292\u2013312. https:\/\/doi.org\/10.1111\/joim.13767.","journal-title":"J Intern Med"},{"issue":"11","key":"3247_CR120","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.3390\/ijms2311604","volume":"23","author":"T Katafuchi","year":"2022","unstructured":"Katafuchi T, Makishima M. Molecular basis of bile acid-FXR-FGF15\/19 signaling axis. Int J Mol Sci. 2022;23(11):6046. https:\/\/doi.org\/10.3390\/ijms2311604.","journal-title":"Int J Mol Sci"},{"issue":"6024","key":"3247_CR121","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1198363","volume":"331","author":"S Kir","year":"2011","unstructured":"Kir S, Beddow SA, Samuel VT, Miller P, Previs SF, Suino-Powell K, et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science. 2011;331(6024):1621\u20134. https:\/\/doi.org\/10.1126\/science.1198363.","journal-title":"Science"},{"issue":"1","key":"3247_CR122","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1038\/s41467-020-19803-9","volume":"11","author":"YC Kim","year":"2020","unstructured":"Kim YC, Seok S, Zhang Y, Ma J, Kong B, Guo G, et al. Intestinal FGF15\/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A. Nat Commun. 2020;11(1):5969. https:\/\/doi.org\/10.1038\/s41467-020-19803-9.","journal-title":"Nat Commun"},{"issue":"1","key":"3247_CR123","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","volume":"3","author":"G Marcelin","year":"2013","unstructured":"Marcelin G, Jo YH, Li X, Schwartz GJ, Zhang Y, Dun NJ, et al. Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism. Mol Metab. 2013;3(1):19\u201328. https:\/\/doi.org\/10.1016\/j.molmet.2013.10.002.","journal-title":"Mol Metab"},{"issue":"1","key":"3247_CR124","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13578-023-00955-2","volume":"13","author":"A Huang","year":"2023","unstructured":"Huang A, Maier MT, Vagena E, Xu AW. Modulation of foraging-like behaviors by cholesterol-FGF19 axis. Cell Biosci. 2023;13(1):20. https:\/\/doi.org\/10.1186\/s13578-023-00955-2.","journal-title":"Cell Biosci"},{"issue":"4","key":"3247_CR125","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.1152\/ajpendo.00488.2024","volume":"328","author":"L Zangerolamo","year":"2025","unstructured":"Zangerolamo L, Carvalho M, Solon C, Sidarta-Oliveira D, Soares GM, Marmentini C, et al. Central FGF19 signaling enhances energy homeostasis and adipose tissue thermogenesis through sympathetic activation in obese mice. Am J Physiol Endocrinol Metab. 2025;328(4):E524\u201342. https:\/\/doi.org\/10.1152\/ajpendo.00488.2024.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3247_CR126","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.molmet.2020.101113","volume":"43","author":"S Mor\u00f3n-Ros","year":"2021","unstructured":"Mor\u00f3n-Ros S, Uriarte I, Berasain C, Avila MA, Sabater-Masdeu M, Moreno-Navarrete JM, et al. FGF15\/19 is required for adipose tissue plasticity in response to thermogenic adaptations. Mol Metab. 2021;43:101113. https:\/\/doi.org\/10.1016\/j.molmet.2020.101113.","journal-title":"Mol Metab"},{"key":"3247_CR127","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molmet.2019.09.006","volume":"30","author":"PJ Antonellis","year":"2019","unstructured":"Antonellis PJ, Droz BA, Cosgrove R, O\u2019Farrell LS, Coskun T, Perfield JW 2nd, et al. The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis. Mol Metab. 2019;30:131\u20139. https:\/\/doi.org\/10.1016\/j.molmet.2019.09.006.","journal-title":"Mol Metab"},{"issue":"6","key":"3247_CR128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11892-017-0866-3","volume":"17","author":"M Izaguirre","year":"2017","unstructured":"Izaguirre M, Gil MJ, Monreal I, Montecucco F, Fr\u00fchbeck G, Catal\u00e1n V. The role and potential therapeutic implications of the fibroblast growth factors in energy balance and type 2 diabetes. Curr Diab Rep. 2017;17(6):43. https:\/\/doi.org\/10.1007\/s11892-017-0866-3.","journal-title":"Curr Diab Rep"},{"issue":"8","key":"3247_CR129","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/db25-0035","volume":"74","author":"F De Vito","year":"2025","unstructured":"De Vito F, Marasco R, Suraci E, Facciolo A, Hribal ML, Sesti G, et al. FXR stimulation by obeticholic acid treatment restores gut mucosa functional and structural integrity in individuals with altered glucose tolerance. Diabetes. 2025;74(8):1399\u2013410. https:\/\/doi.org\/10.2337\/db25-0035.","journal-title":"Diabetes"},{"issue":"5","key":"3247_CR130","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/ijms26051915","volume":"26","author":"DG Ariadel-Cobo","year":"2025","unstructured":"Ariadel-Cobo DG, Est\u00e9banez B, Gonz\u00e1lez-Arn\u00e1iz E, Garc\u00eda-P\u00e9rez MP, Rivera-Viloria M, Pintor de la Maza B, et al. Influence of Klotho protein levels in obesity and sarcopenia: a systematic review. Int J Mol Sci. 2025;26(5):1915. https:\/\/doi.org\/10.3390\/ijms26051915.","journal-title":"Int J Mol Sci."},{"issue":"7","key":"3247_CR131","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1111\/jcmm.16448","volume":"25","author":"J Yu","year":"2021","unstructured":"Yu J, Wu YX, Xiao Q. FGF19 protects skeletal muscle against obesity-induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK\/SIRT-1\/PGC-\u03b1 pathway. J Cell Mol Med. 2021;25(7):3585\u2013600. https:\/\/doi.org\/10.1111\/jcmm.16448.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3247_CR132","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/path.6193","volume":"261","author":"S Mor\u00f3n-Ros","year":"2023","unstructured":"Mor\u00f3n-Ros S, Blasco-Roset A, Navarro-Gascon A, Rup\u00e9rez C, Zamora M, Crispi F, et al. A new FGF15\/19-mediated gut-to-heart axis controls cardiac hypertrophy. J Pathol. 2023;261(3):335\u201348. https:\/\/doi.org\/10.1002\/path.6193.","journal-title":"J Pathol"},{"issue":"1","key":"3247_CR133","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-025-02738-0","volume":"24","author":"M Lin","year":"2025","unstructured":"Lin M, Guo J, Tao H, Gu Z, Tang W, Zhou F, et al. Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis. Cardiovasc Diabetol. 2025;24(1):201. https:\/\/doi.org\/10.1186\/s12933-025-02738-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"3247_CR134","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/14728222.2021.1999416","volume":"25","author":"SK Roberts","year":"2021","unstructured":"Roberts SK, Majeed A. A short report on NGM282\/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH). Expert Opin Ther Targets. 2021;25(10):889\u201395. https:\/\/doi.org\/10.1080\/14728222.2021.1999416.","journal-title":"Expert Opin Ther Targets"},{"key":"3247_CR135","doi-asserted-by":"publisher","first-page":"805722","DOI":"10.3389\/fendo.2021.805722","volume":"12","author":"MN Yang","year":"2022","unstructured":"Yang MN, Huang R, Liu X, Xu YJ, Wang WJ, He H, et al. Fibroblast growth factor 19 in gestational diabetes mellitus and fetal growth. Front Endocrinol (Lausanne). 2022;12:805722. https:\/\/doi.org\/10.3389\/fendo.2021.805722.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3247_CR136","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.placenta.2021.07.286","volume":"112","author":"S Zhao","year":"2021","unstructured":"Zhao S, Wang D, Li Z, Xu S, Chen H, Ding W, et al. FGF15\/FGF19 alleviates insulin resistance and upregulates placental IRS1\/GLUT expression in pregnant mice fed a high-fat diet. Placenta. 2021;112:81\u20138. https:\/\/doi.org\/10.1016\/j.placenta.2021.07.286.","journal-title":"Placenta"},{"issue":"11","key":"3247_CR137","doi-asserted-by":"publisher","first-page":"e81190","DOI":"10.1371\/journal.pone.0081190","volume":"8","author":"D Wang","year":"2013","unstructured":"Wang D, Zhu W, Li J, An C, Wang Z. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS ONE. 2013;8(11):e81190. https:\/\/doi.org\/10.1371\/journal.pone.0081190.","journal-title":"PLoS ONE"},{"issue":"9","key":"3247_CR138","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3390\/jcm11092417","volume":"11","author":"D Karasek","year":"2022","unstructured":"Karasek D, Krystynik O, Kucerova V, Macakova D, Cibickova L, Schovanek J, et al. Adiponectin, A-FABP and FGF-19 levels in women with early diagnosed gestational diabetes. J Clin Med. 2022;11(9):2417. https:\/\/doi.org\/10.3390\/jcm11092417.","journal-title":"J Clin Med"},{"issue":"1","key":"3247_CR139","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/jdi.12859","volume":"10","author":"D Wang","year":"2019","unstructured":"Wang D, Xu S, Ding W, Zhu C, Deng S, Qiu X, et al. Decreased placental and muscular expression of the fibroblast growth factor 19 in gestational diabetes mellitus. J Diabetes Investig. 2019;10(1):171\u201381. https:\/\/doi.org\/10.1111\/jdi.12859.","journal-title":"J Diabetes Investig"},{"issue":"6","key":"3247_CR140","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.modgep.2004.04.005","volume":"4","author":"H Kurose","year":"2004","unstructured":"Kurose H, Bito T, Adachi T, Shimizu M, Noji S, Ohuchi H. Expression of Fibroblast growth factor 19 (Fgf19) during chicken embryogenesis and eye development, compared with Fgf15 expression in the mouse. Gene Expr Patterns. 2004;4(6):687\u201393. https:\/\/doi.org\/10.1016\/j.modgep.2004.04.005.","journal-title":"Gene Expr Patterns"},{"issue":"4","key":"3247_CR141","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/gene.20114","volume":"41","author":"JW Vincentz","year":"2005","unstructured":"Vincentz JW, McWhirter JR, Murre C, Baldini A, Furuta Y. Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis. 2005;41(4):192\u2013201. https:\/\/doi.org\/10.1002\/gene.20114.","journal-title":"Genesis"},{"issue":"3","key":"3247_CR142","doi-asserted-by":"publisher","first-page":"G190","DOI":"10.1152\/ajpgi.00208.2022","volume":"324","author":"C Vonderohe","year":"2023","unstructured":"Vonderohe C, Guthrie G, Burrin DG. Fibroblast growth factor 19 secretion and function in perinatal development. Am J Physiol Gastrointest Liver Physiol. 2023;324(3):G190\u20135. https:\/\/doi.org\/10.1152\/ajpgi.00208.2022.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"3247_CR143","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.mod.2006.07.002","volume":"123","author":"H Saitsu","year":"2006","unstructured":"Saitsu H, Shiota K, Ishibashi M. Analysis of Fibroblast growth factor 15 cis-elements reveals two conserved enhancers which are closely related to cardiac outflow tract development. Mech Dev. 2006;123(9):665\u201373. https:\/\/doi.org\/10.1016\/j.mod.2006.07.002.","journal-title":"Mech Dev"},{"key":"3247_CR144","doi-asserted-by":"publisher","first-page":"568500","DOI":"10.3389\/fendo.2020.568500","volume":"11","author":"M Ramanjaneya","year":"2020","unstructured":"Ramanjaneya M, Bensila M, Bettahi I, Jerobin J, Samra TA, Aye MM, et al. Dynamic changes in circulating endocrine FGF19 subfamily and fetuin-A in response to intralipid and insulin infusions in healthy and PCOS women. Front Endocrinol (Lausanne). 2020;11:568500. https:\/\/doi.org\/10.3389\/fendo.2020.568500.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"3247_CR145","doi-asserted-by":"publisher","first-page":"E864","DOI":"10.1152\/ajpendo.00644.2020","volume":"320","author":"KE Mercer","year":"2021","unstructured":"Mercer KE, Maurer A, Pack LM, Ono-Moore K, Spray BJ, Campbell C, et al. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women. Am J Physiol Endocrinol Metab. 2021;320(5):E864\u201373. https:\/\/doi.org\/10.1152\/ajpendo.00644.2020.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3247_CR146","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exger.2019.03.007","volume":"121","author":"AK Ziegler","year":"2019","unstructured":"Ziegler AK, Jensen SM, Schjerling P, Mackey AL, Andersen JL, Kjaer M. The effect of resistance exercise upon age-related systemic and local skeletal muscle inflammation. Exp Gerontol. 2019;121:19\u201332. https:\/\/doi.org\/10.1016\/j.exger.2019.03.007.","journal-title":"Exp Gerontol"},{"issue":"15","key":"3247_CR147","doi-asserted-by":"publisher","first-page":"e122737","DOI":"10.1172\/jci.insight.122737","volume":"3","author":"T Morville","year":"2018","unstructured":"Morville T, Sahl RE, Trammell SA, Svenningsen JS, Gillum MP, Helge JW, et al. Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans. JCI Insight. 2018;3(15):e122737. https:\/\/doi.org\/10.1172\/jci.insight.122737.","journal-title":"JCI Insight"},{"issue":"1","key":"3247_CR148","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11010-024-04982-6","volume":"480","author":"MA Rivoira","year":"2025","unstructured":"Rivoira MA, Peralta L\u00f3pez ME, Areco V, D\u00edaz de Barboza G, Dionisi MP, Tolosa de Talamoni N. Emerging concepts on the FGF23 regulation and activity. Mol Cell Biochem. 2025;480(1):75\u201389. https:\/\/doi.org\/10.1007\/s11010-024-04982-6.","journal-title":"Mol Cell Biochem."},{"issue":"1","key":"3247_CR149","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41387-018-0037-x","volume":"8","author":"P Glosse","year":"2018","unstructured":"Glosse P, Fajol A, Hirche F, Feger M, Voelkl J, Lang F, et al. A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNF\u03b1 upregulation. Nutr Diabetes. 2018;8(1):36. https:\/\/doi.org\/10.1038\/s41387-018-0037-x.","journal-title":"Nutr Diabetes"},{"issue":"1","key":"3247_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58663-7","volume":"10","author":"A Vidal","year":"2020","unstructured":"Vidal A, Rios R, Pineda C, Lopez I, Mu\u00f1oz-Casta\u00f1eda JR, Rodriguez M, et al. Direct regulation of fibroblast growth factor 23 by energy intake through mTOR. Sci Rep. 2020;10(1):1795. https:\/\/doi.org\/10.1038\/s41598-020-58663-7.","journal-title":"Sci Rep"},{"issue":"3","key":"3247_CR151","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.kint.2018.03.006","volume":"94","author":"P Glosse","year":"2018","unstructured":"Glosse P, Feger M, Mutig K, Chen H, Hirche F, Hasan AA, et al. AMP-activated kinase is a regulator of fibroblast growth factor 23 production. Kidney Int. 2018;94(3):491\u2013501. https:\/\/doi.org\/10.1016\/j.kint.2018.03.006.","journal-title":"Kidney Int"},{"issue":"22","key":"3247_CR152","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.1800160115","volume":"115","author":"L B\u00e4r","year":"2018","unstructured":"B\u00e4r L, Feger M, Fajol A, Klotz LO, Zeng S, Lang F, et al. Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc Natl Acad Sci U S A. 2018;115(22):5804\u20139. https:\/\/doi.org\/10.1073\/pnas.1800160115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3247_CR153","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MNH.0000000000000995","volume":"33","author":"G Courbon","year":"2024","unstructured":"Courbon G, David V. Fibroblast growth factor 23 is pumping iron: c-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism. Curr Opin Nephrol Hypertens. 2024;33(4):368\u201374. https:\/\/doi.org\/10.1097\/MNH.0000000000000995.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3247_CR154","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2016.11.013","volume":"100","author":"M Kuro-O","year":"2017","unstructured":"Kuro-O M, Moe OW. FGF23-\u03b1Klotho as a paradigm for a kidney-bone network. Bone. 2017;100:4\u201318. https:\/\/doi.org\/10.1016\/j.bone.2016.11.013.","journal-title":"Bone"},{"issue":"5","key":"3247_CR155","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, et al. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int. 2016;90(5):985\u201396. https:\/\/doi.org\/10.1016\/j.kint.2016.05.019.","journal-title":"Kidney Int"},{"issue":"2","key":"3247_CR156","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/JME-20-0178","volume":"66","author":"BB Ho","year":"2021","unstructured":"Ho BB, Bergwitz C. FGF23 signalling and physiology. J Mol Endocrinol. 2021;66(2):R23\u201332. https:\/\/doi.org\/10.1530\/JME-20-0178.","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"3247_CR157","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.3390\/ijms25094875","volume":"25","author":"L Mart\u00ednez-Heredia","year":"2024","unstructured":"Mart\u00ednez-Heredia L, Canelo-Moreno JM, Garc\u00eda-Fontana B, Mu\u00f1oz-Torres M. Non-classical effects of FGF23: molecular and clinical features. Int J Mol Sci. 2024;25(9):4875. https:\/\/doi.org\/10.3390\/ijms25094875.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3247_CR158","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI19081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Investig. 2004;113(4):561\u20138. https:\/\/doi.org\/10.1172\/JCI19081.","journal-title":"J Clin Investig"},{"issue":"4","key":"3247_CR159","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, et al. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2005;280(4):2543. https:\/\/doi.org\/10.1074\/jbc.M408903200.","journal-title":"J Biol Chem"},{"issue":"2","key":"3247_CR160","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11154-015-9318-z","volume":"16","author":"JE Blau","year":"2015","unstructured":"Blau JE, Collins MT. The PTH-vitamin D-FGF23 axis. Rev Endocr Metab Disord. 2015;16(2):165\u201374. https:\/\/doi.org\/10.1007\/s11154-015-9318-z.","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"3247_CR161","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/toxins11110647","volume":"11","author":"I Vogt","year":"2019","unstructured":"Vogt I, Haffner D, Leifheit-Nestler M. FGF23 and phosphate-cardiovascular toxins in CKD. Toxins (Basel). 2019;11(11):647. https:\/\/doi.org\/10.3390\/toxins11110647.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"3247_CR162","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ki.2009.464","volume":"77","author":"H Galitzer","year":"2010","unstructured":"Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 2010;77(3):211\u20138. https:\/\/doi.org\/10.1038\/ki.2009.464.","journal-title":"Kidney Int"},{"issue":"1","key":"3247_CR163","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/medsci13010027","volume":"13","author":"J Oliveira-Sousa","year":"2025","unstructured":"Oliveira-Sousa J, Frag\u00e3o-Marques M, Duarte-Gamas L, Ribeiro H, Rocha-Neves J. FGF-23 as a biomarker for carotid plaque vulnerability: a systematic review. Med Sci Basel. 2025;13(1):27. https:\/\/doi.org\/10.3390\/medsci13010027.","journal-title":"Med Sci Basel"},{"issue":"10","key":"3247_CR164","doi-asserted-by":"publisher","first-page":"e971","DOI":"10.1210\/clinem\/dgad246","volume":"108","author":"A van der Vaart","year":"2023","unstructured":"van der Vaart A, Eelderink C, van Beek AP, Bakker SJL, van Dijk PR, de Borst MH. Fibroblast growth factor 23, glucose homeostasis, and incident diabetes: findings of 2 cohort studies. J Clin Endocrinol Metab. 2023;108(10):e971\u20138. https:\/\/doi.org\/10.1210\/clinem\/dgad246.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3247_CR165","doi-asserted-by":"publisher","first-page":"13999","DOI":"10.1038\/s41598-018-32432-z","volume":"8","author":"A Nakashima","year":"2018","unstructured":"Nakashima A, Yokoyama K, Kawanami D, Ohkido I, Urashima M, Utsunomiya K, et al. Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus. Sci Rep. 2018;8(1):13999. https:\/\/doi.org\/10.1038\/s41598-018-32432-z.","journal-title":"Sci Rep"},{"key":"3247_CR166","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.11.149","volume":"138","author":"X Han","year":"2020","unstructured":"Han X, Cai C, Xiao Z, Quarles LD. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. J Mol Cell Cardiol. 2020;138:66\u201374. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.11.149.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"3247_CR167","doi-asserted-by":"publisher","first-page":"bvab187","DOI":"10.1210\/jendso\/bvab187","volume":"6","author":"K Okamoto","year":"2021","unstructured":"Okamoto K, Fujii H, Watanabe K, Goto S, Kono K, Nishi S. Changes of FGF23 and the renin-angiotensin-system in male mouse models of chronic kidney disease and cardiac hypertrophy. J Endocr Soc. 2021;6(2):bvab187. https:\/\/doi.org\/10.1210\/jendso\/bvab187.","journal-title":"J Endocr Soc."},{"issue":"2","key":"3247_CR168","doi-asserted-by":"publisher","first-page":"101826","DOI":"10.1016\/j.beem.2023.101826","volume":"38","author":"A Goyal","year":"2024","unstructured":"Goyal A, Tandon N. Burosumab: current status and future prospects. Best Pract Res Clin Endocrinol Metab. 2024;38(2):101826. https:\/\/doi.org\/10.1016\/j.beem.2023.101826.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"3247_CR169","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1590\/2359-3997000000287","volume":"61","author":"M Kizilgul","year":"2017","unstructured":"Kizilgul M, Kan S, Beysel S, Apaydin M, Ozcelik O, Caliskan M, et al. Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes? Arch Endocrinol Metab. 2017;61(6):562\u20136. https:\/\/doi.org\/10.1590\/2359-3997000000287.","journal-title":"Arch Endocrinol Metab"},{"key":"3247_CR170","doi-asserted-by":"publisher","first-page":"156508","DOI":"10.1016\/j.cyto.2024.156508","volume":"176","author":"S Zhao","year":"2024","unstructured":"Zhao S, Zhou J, Chen R, Zhou W, Geng H, Huang Y, et al. Decreased FGF23 inhibits placental angiogenesis via the ERK1\/2-EGR-1 signaling pathway in preeclampsia. Cytokine. 2024;176:156508. https:\/\/doi.org\/10.1016\/j.cyto.2024.156508.","journal-title":"Cytokine"},{"issue":"8","key":"3247_CR171","doi-asserted-by":"publisher","first-page":"e3704","DOI":"10.1002\/dmrr.3704","volume":"39","author":"CF Hocher","year":"2023","unstructured":"Hocher CF, Chen X, Zuo J, Horvathova K, Hocher B, Kr\u00e4mer BK, et al. Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitus. Diabetes Metab Res Rev. 2023;39(8):e3704. https:\/\/doi.org\/10.1002\/dmrr.3704.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"3247_CR172","doi-asserted-by":"publisher","first-page":"bqaa202","DOI":"10.1210\/endocr\/bqaa202","volume":"162","author":"KB Sellars","year":"2021","unstructured":"Sellars KB, Ryan BA, Hartery SA, Kirby BJ, Kovacs CS. Murine fetal serum phosphorus is set independent of FGF23 and PTH, except in the presence of maternal phosphate loading. Endocrinology. 2021;162(1):bqaa202. https:\/\/doi.org\/10.1210\/endocr\/bqaa202.","journal-title":"Endocrinology"},{"issue":"2","key":"3247_CR173","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1210\/en.2016-1369","volume":"158","author":"Y Ma","year":"2017","unstructured":"Ma Y, Kirby BJ, Fairbridge NA, Karaplis AC, Lanske B, Kovacs CS. FGF23 is not required to regulate fetal phosphorus metabolism but exerts effects within 12 hours after birth. Endocrinology. 2017;158(2):252\u201363. https:\/\/doi.org\/10.1210\/en.2016-1369.","journal-title":"Endocrinology"},{"issue":"7","key":"3247_CR174","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3390\/nu13072202","volume":"13","author":"A Leone","year":"2021","unstructured":"Leone A, Mart\u00ednez-Gonz\u00e1lez M\u00c1, Craig W, Fres\u00e1n U, G\u00f3mez-Donoso C, Bes-Rastrollo M. Pre-gestational consumption of ultra-processed foods and risk of gestational diabetes in a Mediterranean cohort. The SUN Project. Nutrients. 2021;13(7):2202. https:\/\/doi.org\/10.3390\/nu13072202.","journal-title":"Nutrients"},{"issue":"1","key":"3247_CR175","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.1038\/s41598-025-91717-2","volume":"15","author":"M Hayashi-Suzuki","year":"2025","unstructured":"Hayashi-Suzuki M, Fukuda-Tatano S, Kishimoto-Ogata M, Ehara-Kawagishi M, Ohminami H, Masuda M, et al. Maternal excess dietary phosphate intake in the periconceptional period is a potential risk for mineral disorders in offspring mice. Sci Rep. 2025;15(1):8844. https:\/\/doi.org\/10.1038\/s41598-025-91717-2.","journal-title":"Sci Rep"},{"issue":"5","key":"3247_CR176","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.metabol.2016.02.009","volume":"65","author":"DJ Li","year":"2016","unstructured":"Li DJ, Fu H, Zhao T, Ni M, Shen FM. Exercise-stimulated FGF23 promotes exercise performance via controlling the excess reactive oxygen species production and enhancing mitochondrial function in skeletal muscle. Metabolism. 2016;65(5):747\u201356. https:\/\/doi.org\/10.1016\/j.metabol.2016.02.009.","journal-title":"Metabolism"},{"issue":"7","key":"3247_CR177","doi-asserted-by":"publisher","first-page":"114397","DOI":"10.1016\/j.celrep.2024.114397","volume":"43","author":"E Sakamoto","year":"2024","unstructured":"Sakamoto E, Kitase Y, Fitt AJ, Zhu Z, Awad K, Brotto M, et al. Both enantiomers of \u03b2-aminoisobutyric acid BAIBA regulate Fgf23 via MRGPRD receptor by activating distinct signaling pathways in osteocytes. Cell Rep. 2024;43(7):114397. https:\/\/doi.org\/10.1016\/j.celrep.2024.114397.","journal-title":"Cell Rep"},{"issue":"4","key":"3247_CR178","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41581-022-00675-9","volume":"19","author":"NC Bishop","year":"2023","unstructured":"Bishop NC, Burton JO, Graham-Brown MPM, Stensel DJ, Viana JL, Watson EL. Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits. Nat Rev Nephrol. 2023;19(4):244\u201356. https:\/\/doi.org\/10.1038\/s41581-022-00675-9.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"3247_CR179","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1152\/japplphysiol.00416.2020","volume":"130","author":"RVP Neves","year":"2021","unstructured":"Neves RVP, Corr\u00eaa HL, Deus LA, Reis AL, Souza MK, Sim\u00f5es HG, et al. Dynamic not isometric training blunts osteo-renal disease and improves the sclerostin\/FGF23\/Klotho axis in maintenance hemodialysis patients: a randomized clinical trial. J Appl Physiol. 2021;130(2):508\u201316. https:\/\/doi.org\/10.1152\/japplphysiol.00416.2020.","journal-title":"J Appl Physiol"},{"issue":"18","key":"3247_CR180","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/nu14183772","volume":"14","author":"SI Karampatsou","year":"2022","unstructured":"Karampatsou SI, Paltoglou G, Genitsaridi SM, Kassari P, Charmandari E. The effect of a comprehensive life-style intervention program of diet and exercise on four bone-derived proteins, FGF-23, osteopontin, NGAL and sclerostin, in overweight or obese children and adolescents. Nutrients. 2022;14(18):3772. https:\/\/doi.org\/10.3390\/nu14183772.","journal-title":"Nutrients"},{"issue":"3","key":"3247_CR181","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cardfail.2020.09.477","volume":"27","author":"J Ghuman","year":"2021","unstructured":"Ghuman J, Cai X, Patel RB, Khan SS, Hecktman J, Redfield MM, et al. Fibroblast growth factor 23 and exercise capacity in heart failure with preserved ejection fraction. J Card Fail. 2021;27(3):309\u201317. https:\/\/doi.org\/10.1016\/j.cardfail.2020.09.477.","journal-title":"J Card Fail"},{"issue":"2","key":"3247_CR182","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7150\/ijms.90195","volume":"21","author":"RF Castillo","year":"2024","unstructured":"Castillo RF, P\u00e9rez RG, Gonz\u00e1lez AL. Beneficial effects of physical exercise on the osteo-renal Klotho-FGF-23 axis in chronic kidney disease: a systematic review with meta-analysis. Int J Med Sci. 2024;21(2):332\u201340. https:\/\/doi.org\/10.7150\/ijms.90195.","journal-title":"Int J Med Sci"},{"issue":"5742","key":"3247_CR183","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309(5742):1829\u201333. https:\/\/doi.org\/10.1126\/science.1112766.","journal-title":"Science"},{"issue":"45","key":"3247_CR184","doi-asserted-by":"publisher","first-page":"38029","DOI":"10.1074\/jbc.M509039200","volume":"280","author":"M Yamamoto","year":"2005","unstructured":"Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, Kurosu H, et al. Regulation of oxidative stress by the anti-aging hormone Klotho. J Biol Chem. 2005;280(45):38029\u201334. https:\/\/doi.org\/10.1074\/jbc.M509039200.","journal-title":"J Biol Chem"},{"issue":"1","key":"3247_CR185","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41467-022-28096-z","volume":"13","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Ren Q, Li L, Tan H, Lu M, Tian Y, et al. A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-\u03b2 signaling. Nat Commun. 2022;13(1):438. https:\/\/doi.org\/10.1038\/s41467-022-28096-z.","journal-title":"Nat Commun"},{"issue":"10","key":"3247_CR186","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1074\/jbc.M110.174037","volume":"286","author":"S Doi","year":"2011","unstructured":"Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011;286(10):8655\u201365. https:\/\/doi.org\/10.1074\/jbc.M110.174037.","journal-title":"J Biol Chem"},{"issue":"6","key":"3247_CR187","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1089\/rej.2018.2092","volume":"22","author":"FJ Amaro-Gahete","year":"2019","unstructured":"Amaro-Gahete FJ, De-la-O A, Jurado-Fasoli L, Espuch-Oliver A, de Haro T, Guti\u00e9rrez \u00c1, et al. Body composition and S-Klotho plasma levels in middle-aged adults: a cross-sectional study. Rejuvenation Res. 2019;22(6):478\u201383. https:\/\/doi.org\/10.1089\/rej.2018.2092.","journal-title":"Rejuvenation Res"},{"issue":"1","key":"3247_CR188","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbadis.2017.09.029","volume":"1864","author":"Y Guo","year":"2018","unstructured":"Guo Y, Zhuang X, Huang Z, Zou J, Yang D, Hu X, et al. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-\u03baB-mediated inflammation both in vitro and in vivo. Biochim Biophys Acta Mol Basis Dis. 2018;1864(1):238\u201351. https:\/\/doi.org\/10.1016\/j.bbadis.2017.09.029.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"3247_CR189","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/CIRCRESAHA.120.317348","volume":"128","author":"K Chen","year":"2021","unstructured":"Chen K, Wang S, Sun QW, Zhang B, Ullah M, Sun Z. Klotho deficiency causes heart aging via impairing the Nrf2-GR pathway. Circ Res. 2021;128(4):492\u2013507. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317348.","journal-title":"Circ Res"},{"issue":"2","key":"3247_CR190","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/antiox12020239","volume":"12","author":"J Donate-Correa","year":"2023","unstructured":"Donate-Correa J, Mart\u00edn-Carro B, Cannata-And\u00eda JB, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF. Klotho, oxidative stress, and mitochondrial damage in kidney disease. Antioxidants (Basel). 2023;12(2):239. https:\/\/doi.org\/10.3390\/antiox12020239.","journal-title":"Antioxidants (Basel)"},{"key":"3247_CR191","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.placenta.2025.04.024","volume":"167","author":"J Niu","year":"2025","unstructured":"Niu J, Han B, Wang S, Wei Y, Liu Z, Yang H. Hyperglycemia-induced \u03b1-Klotho downregulation impairs mitophagy and promotes placental dysfunction in T2DM pregnancies. Placenta. 2025;167:95\u2013103. https:\/\/doi.org\/10.1016\/j.placenta.2025.04.024.","journal-title":"Placenta"},{"issue":"1","key":"3247_CR192","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13008-024-00120-2","volume":"19","author":"B Xu","year":"2024","unstructured":"Xu B, Cheng F, Xue X. Klotho-mediated activation of the anti-oxidant Nrf2\/ARE signal pathway affects cell apoptosis, senescence and mobility in hypoxic human trophoblasts: involvement of Klotho in the pathogenesis of preeclampsia. Cell Div. 2024;19(1):13. https:\/\/doi.org\/10.1186\/s13008-024-00120-2.","journal-title":"Cell Div"},{"issue":"2","key":"3247_CR193","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1874609811666180702101338","volume":"11","author":"FJ Amaro-Gahete","year":"2018","unstructured":"Amaro-Gahete FJ, de-la-O A, Jurado-Fasoli L, Ruiz JR, Castillo MJ, Guti\u00e9rrez \u00c1. Role of exercise on S-Klotho protein regulation: a systematic review. Curr Aging Sci. 2018;11(2):100\u20137. https:\/\/doi.org\/10.2174\/1874609811666180702101338.","journal-title":"Curr Aging Sci"},{"issue":"1","key":"3247_CR194","doi-asserted-by":"publisher","first-page":"17587","DOI":"10.1038\/s41598-022-22123-1","volume":"12","author":"HL Corr\u00eaa","year":"2022","unstructured":"Corr\u00eaa HL, Raab ATO, Ara\u00fajo TM, Deus LA, Reis AL, Honorato FS, et al. A systematic review and meta-analysis demonstrating Klotho as an emerging exerkine. Sci Rep. 2022;12(1):17587. https:\/\/doi.org\/10.1038\/s41598-022-22123-1.","journal-title":"Sci Rep"},{"issue":"4","key":"3247_CR195","doi-asserted-by":"publisher","first-page":"577","DOI":"10.33549\/physiolres.935290","volume":"73","author":"XK Yuan","year":"2024","unstructured":"Yuan XK, Ni PS, Yan ZH, Yu Z, Wang ZZ, Zhang CK, et al. Effects of life-long exercise on age-related inflammation, apoptosis, oxidative stress, ferroptosis markers, and NRF2\/KAEP 1\/Klotho pathway in rat kidneys. Physiol Res. 2024;73(4):577\u201391. https:\/\/doi.org\/10.33549\/physiolres.935290.","journal-title":"Physiol Res"},{"issue":"19","key":"3247_CR196","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/02640414.2019.1626048","volume":"37","author":"FJ Amaro-Gahete","year":"2019","unstructured":"Amaro-Gahete FJ, De-la-O A, Jurado-Fasoli L, Espuch-Oliver A, de Haro T, Gutierrez A, et al. Exercise training increases the S-Klotho plasma levels in sedentary middle-aged adults: a randomised controlled trial. The FIT-AGEING study. J Sports Sci. 2019;37(19):2175\u201383. https:\/\/doi.org\/10.1080\/02640414.2019.1626048.","journal-title":"J Sports Sci"},{"issue":"2","key":"3247_CR197","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13105-023-01005-8","volume":"80","author":"G Navarro-Lomas","year":"2024","unstructured":"Navarro-Lomas G, Plaza-Florido A, De-la-O A, Castillo MJ, Amaro-Gahete FJ. Exercise-induced changes in plasma S-Klotho levels are associated with the obtained enhancements of heart rate variability in sedentary middle-aged adults: the FIT-AGEING study. J Physiol Biochem. 2024;80(2):317\u201328. https:\/\/doi.org\/10.1007\/s13105-023-01005-8.","journal-title":"J Physiol Biochem"},{"key":"3247_CR198","doi-asserted-by":"publisher","first-page":"109747","DOI":"10.1016\/j.jnutbio.2024.109747","volume":"134","author":"IVS Neto","year":"2024","unstructured":"Neto IVS, Pinto AP, de Andrade RV, de Souza FHV, de Souza PEN, Assis V, et al. Paternal exercise induces antioxidant defenses by \u03b1-Klotho\/Keap1 pathways in the skeletal muscle of offspring exposed to a high fat-diet without changing telomere length. J Nutr Biochem. 2024;134:109747. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109747.","journal-title":"J Nutr Biochem"},{"key":"3247_CR199","doi-asserted-by":"publisher","first-page":"712572","DOI":"10.3389\/fimmu.2021.712572","volume":"12","author":"J Barratt","year":"2021","unstructured":"Barratt J, Weitz I. Complement factor D as a strategic target for regulating the alternative complement pathway. Front Immunol. 2021;12:712572. https:\/\/doi.org\/10.3389\/fimmu.2021.712572.","journal-title":"Front Immunol"},{"issue":"2","key":"3247_CR200","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dbi23-0005","volume":"73","author":"A Gilani","year":"2024","unstructured":"Gilani A, Stoll L, Homan EA, Lo JC. Adipose signals regulating distal organ health and disease. Diabetes. 2024;73(2):169\u201377. https:\/\/doi.org\/10.2337\/dbi23-0005.","journal-title":"Diabetes"},{"issue":"1","key":"3247_CR201","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","volume":"158","author":"JC Lo","year":"2014","unstructured":"Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, et al. Adipsin is an adipokine that improves \u03b2 cell function in diabetes. Cell. 2014;158(1):41\u201353. https:\/\/doi.org\/10.1016\/j.cell.2014.06.005.","journal-title":"Cell"},{"key":"3247_CR202","doi-asserted-by":"publisher","first-page":"102134","DOI":"10.1016\/j.molmet.2025.102134","volume":"96","author":"R Pereira de Lima","year":"2025","unstructured":"Pereira de Lima R, Li A, Gilani A, Rubio-Navarro A, Warren CD, Kong IY, et al. C3aR1 on \u03b2 cells enhances \u03b2 cell function and survival to maintain glucose homeostasis. Mol Metab. 2025;96:102134. https:\/\/doi.org\/10.1016\/j.molmet.2025.102134.","journal-title":"Mol Metab"},{"issue":"11","key":"3247_CR203","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41591-019-0610-4","volume":"25","author":"N G\u00f3mez-Banoy","year":"2019","unstructured":"G\u00f3mez-Banoy N, Guseh JS, Li G, Rubio-Navarro A, Chen T, Poirier B, et al. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. Nat Med. 2019;25(11):1739\u201347. https:\/\/doi.org\/10.1038\/s41591-019-0610-4.","journal-title":"Nat Med"},{"issue":"11","key":"3247_CR204","doi-asserted-by":"publisher","first-page":"e178925","DOI":"10.1172\/jci.insight.178925","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Gilani A, Rubio-Navarro A, Cortada E, Li A, Reilly SM, et al. Adipsin and adipocyte-derived C3aR1 regulate thermogenic fat in a sex-dependent fashion. JCI Insight. 2024;9(11):e178925. https:\/\/doi.org\/10.1172\/jci.insight.178925.","journal-title":"JCI Insight"},{"key":"3247_CR205","doi-asserted-by":"publisher","first-page":"667330","DOI":"10.3389\/fphys.2021.667330","volume":"12","author":"D Guo","year":"2021","unstructured":"Guo D, Liu J, Zhang P, Yang X, Liu D, Lin J, et al. Adiposity measurements and metabolic syndrome are linked through circulating Neuregulin 4 and adipsin levels in obese adults. Front Physiol. 2021;12:667330. https:\/\/doi.org\/10.3389\/fphys.2021.667330.","journal-title":"Front Physiol"},{"issue":"2","key":"3247_CR206","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/js.2018-00359","volume":"3","author":"JS Wang","year":"2018","unstructured":"Wang JS, Lee WJ, Lee IT, Lin SY, Lee WL, Liang KW, et al. Association between serum adipsin levels and insulin resistance in subjects with various degrees of glucose intolerance. J Endocr Soc. 2018;3(2):403\u201310. https:\/\/doi.org\/10.1210\/js.2018-00359.","journal-title":"J Endocr Soc"},{"issue":"4","key":"3247_CR207","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/ijms23042222","volume":"23","author":"M Milek","year":"2022","unstructured":"Milek M, Moulla Y, Kern M, Stroh C, Dietrich A, Sch\u00f6n MR, et al. Adipsin serum concentrations and adipose tissue expression in people with obesity and type 2 diabetes. Int J Mol Sci. 2022;23(4):2222. https:\/\/doi.org\/10.3390\/ijms23042222.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3247_CR208","doi-asserted-by":"publisher","first-page":"166533","DOI":"10.1016\/j.bbadis.2022.166533","volume":"1868","author":"Y Duan","year":"2022","unstructured":"Duan Y, Zhang X, Zhang X, Lin J, Shu X, Man W, et al. Inhibition of macrophage-derived foam cells by adipsin attenuates progression of atherosclerosis. Biochim Biophys Acta Mol Basis Dis. 2022;1868(12):166533. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166533.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"3247_CR209","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1152\/ajpendo.00440.2020","volume":"320","author":"L Liu","year":"2021","unstructured":"Liu L, Chan M, Yu L, Wang W, Qiang L. Adipsin deficiency does not impact atherosclerosis development in Ldlr-\/- mice. Am J Physiol Endocrinol Metab. 2021;320(1):E87\u201392. https:\/\/doi.org\/10.1152\/ajpendo.00440.2020.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3247_CR210","doi-asserted-by":"publisher","first-page":"107270","DOI":"10.1016\/j.vph.2023.107270","volume":"154","author":"A Dare","year":"2024","unstructured":"Dare A, Chen SY. Adipsin in the pathogenesis of cardiovascular diseases. Vascul Pharmacol. 2024;154:107270. https:\/\/doi.org\/10.1016\/j.vph.2023.107270.","journal-title":"Vascul Pharmacol"},{"issue":"23","key":"3247_CR211","doi-asserted-by":"publisher","first-page":"e013716","DOI":"10.1161\/JAHA.119.013716","volume":"8","author":"T Ohtsuki","year":"2019","unstructured":"Ohtsuki T, Satoh K, Shimizu T, Ikeda S, Kikuchi N, Satoh T, et al. Identification of adipsin as a novel prognostic biomarker in patients with coronary artery disease. J Am Heart Assoc. 2019;8(23):e013716. https:\/\/doi.org\/10.1161\/JAHA.119.013716.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3247_CR212","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-023-02887-7","volume":"21","author":"X Zhang","year":"2023","unstructured":"Zhang X, Duan Y, Zhang X, Jiang M, Man W, Zhang Y, et al. Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism. BMC Med. 2023;21(1):197. https:\/\/doi.org\/10.1186\/s12916-023-02887-7.","journal-title":"BMC Med"},{"issue":"5","key":"3247_CR213","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1210\/clinem\/dgad699","volume":"109","author":"CJ McElwain","year":"2024","unstructured":"McElwain CJ, Manna S, Musumeci A, Sylvester I, Rouchon C, O\u2019Callaghan AM, et al. Defective visceral adipose tissue adaptation in gestational diabetes mellitus. J Clin Endocrinol Metab. 2024;109(5):1275\u201384. https:\/\/doi.org\/10.1210\/clinem\/dgad699.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3247_CR214","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12933-025-02744-2","volume":"24","author":"M Cai","year":"2025","unstructured":"Cai M, Jiang X, Xu X, Zhao S, Sun Y, Yang Y, et al. Integrating adipsin with novel cardiometabolic and inflammatory indices for enhanced early prediction of gestational diabetes mellitus: a prospective cohort study. Cardiovasc Diabetol. 2025;24(1):189. https:\/\/doi.org\/10.1186\/s12933-025-02744-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3247_CR215","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2021.0083","author":"R Saucedo","year":"2021","unstructured":"Saucedo R, Valencia J, Moreno-Gonz\u00e1lez LE, Pe\u00f1a-Cano MI, Aranda-Mart\u00ednez A, Garc\u00eda Y, et al. Maternal serum adipokines and inflammatory markers at late gestation and newborn weight in mothers with and without gestational diabetes mellitus. Ginekol Pol. 2021. https:\/\/doi.org\/10.5603\/GP.a2021.0083.","journal-title":"Ginekol Pol"},{"key":"3247_CR216","doi-asserted-by":"publisher","first-page":"702385","DOI":"10.3389\/fimmu.2021.702385","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu M, Luo X, Xu Q, Yu H, Gao L, Zhou R, et al. Adipsin of the Alternative Complement Pathway is a potential predictor for preeclampsia in early pregnancy. Front Immunol. 2021;12:702385. https:\/\/doi.org\/10.3389\/fimmu.2021.702385.","journal-title":"Front Immunol"},{"key":"3247_CR217","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1074\/mcp.TIR120.002343","volume":"20","author":"SF Martinez-Huenchullan","year":"2021","unstructured":"Martinez-Huenchullan SF, Shipsey I, Hatchwell L, Min D, Twigg SM, Larance M. Blockade of high-fat diet proteomic phenotypes using exercise as prevention or treatment. Mol Cell Proteomics. 2021;20:100027. https:\/\/doi.org\/10.1074\/mcp.TIR120.002343.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"3247_CR218","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/nu15010019","volume":"15","author":"Z Shi","year":"2022","unstructured":"Shi Z, Wang L, Luan J, Yin L, Ji X, Zhang W, et al. Exercise promotes bone marrow microenvironment by inhibiting adipsin in diet-induced male obese mice. Nutrients. 2022;15(1):19. https:\/\/doi.org\/10.3390\/nu15010019.","journal-title":"Nutrients"},{"issue":"3","key":"3247_CR219","doi-asserted-by":"publisher","first-page":"292","DOI":"10.23736\/S0031-0808.21.04382-2","volume":"65","author":"M Lenz","year":"2023","unstructured":"Lenz M, Sch\u00f6nbauer R, Stojkovic S, Lichtenauer M, Paar V, Gatterer C, et al. Long-term physical activity modulates adipsin and ANGPTL4 serum levels, a potential link to exercise-induced metabolic changes. Panminerva Med. 2023;65(3):292\u2013302. https:\/\/doi.org\/10.23736\/S0031-0808.21.04382-2.","journal-title":"Panminerva Med"},{"issue":"3","key":"3247_CR220","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08977194.2024.2378889","volume":"42","author":"Y Hikmat","year":"2024","unstructured":"Hikmat Y, Safarzade A, Alizadeh H. Comparative effects of 8-week combined resistance exercise training and alternate-day calorie restriction on soluble epidermal growth factor receptor (sEGFR) and adipsin in obese men. Growth Factors. 2024;42(3):111\u20139. https:\/\/doi.org\/10.1080\/08977194.2024.2378889.","journal-title":"Growth Factors"},{"issue":"4","key":"3247_CR221","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1297\/cpe.2025-0038","volume":"34","author":"MD Caba-Flores","year":"2025","unstructured":"Caba-Flores MD, Huerta-Canseco C, Mart\u00ednez-Valenzuela C, de Jes\u00fas Garza-Ju\u00e1rez A, Rivas-Estilla AM, Camacho-Morales A. Adipocytokine profiles in maternal obesity: the impact of lipoinflammation on serum, breastmilk, and infant metabolic development. Clin Pediatr Endocrinol. 2025;34(4):204\u201312. https:\/\/doi.org\/10.1297\/cpe.2025-0038.","journal-title":"Clin Pediatr Endocrinol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03247-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03247-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03247-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:02:09Z","timestamp":1787151729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03247-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":221,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3247"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03247-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"243"}}